§ 428.404 Manufacturer access to Rebate Reports.
(a) General. CMS will establish a method and process for a manufacturer of the Part D rebatable drug to:
(1) Access the Rebate Report as set forth in §§ 428.401 and 428.402, including any report of a reconciled rebate amount as set forth in §§ 428.401 and 428.402;
(2) Submit a Suggestion of Error as set forth in §§ 428.402(c) and 428.403; and
(3) Pay a rebate amount as set forth in § 428.405.
(b) [Reserved]